A tool to evaluate the wind, temperature and other meteorological variables to optimize the use of renewable energy in the european electricity market.
Mafalda deals with two aspects of dedicated fibre lasers: (1) the development and valorisation of a low cost solution for specific micro-surgery applications and (2) showing the technology's reliability and capacity for dealing with demands from powerful modern medical and non-medical applications.
To develop and integrate a multi sensor solution for the detection, analysis and characterisation of sub-surface features using non-destructive techniques.
The project will review and define quality parameters for optimising yield management that may be measured online from slaughter to packing. The sensors would include: vision, specialised optics, contact and force, x-ray and chemical sensors.
Development of aerial unmanned vehicles and related sensors for remote monitoring.
Design and industrialisation of an innovative process for controlling the level of alcohol during wine production. The process will be environment-friendly and provide sugar recycling.
This project is focussed on the development of an automatic, combined system for the complete identification of vehicles. This device has three different modules, including both hardware and software levels: 1.-Number plate recognition; 2.-Colour recognition; 3.-Magnetic recognition.
This project is devoted to research and development of novel metamaterial-based (mtm-based) passive and active sensing devices for agricultural, environmental and in-ground detection applications. High performance and compact soil-moisture sensors and ground penetrating radars are envisaged.
The project aims to obtain high added value natural ingredients from local plants using sustainable green-technologies. Sharing knowledge in separation technologies, supercritical fluid extraction and molecular distillation, will allow both companies to efficiently use resources to reach this goal
A computer centric method for designing drug-like molecules using fragments will be developed by combining proprietary technology from acellera labs and hql pharmaceuticals. The methodology, will be validated by developing small molecule inhibitors of chemokines, biokine's field of expertise.